The prevalence of gynecological issues in women such as polycystic ovary disease (POCD), menorrhagia, abnormal vaginal bleeding, and cervical cancer has increased and is a major factor contributing to the growth of the market .
USA, Rockville MD, Aug. 29, 2022 (GLOBE NEWSWIRE) — According to the latest industry analysis from Fact.MR, a market research and competitive intelligence provider, the sale of endometrial ablation devices is currently valued at over US$1 billion and is expected to grow at a CAGR of 4% through 2027.
The endometrial lining of the uterus is removed or destroyed during an endometrial ablation operation to treat heavy monthly bleeding. The endometrial ablation devices market is expected to grow at a faster than average rate over the forecast period owing to factors such as increasing prevalence of menorrhagia, increased awareness of endometrial ablation, endometrium and increase request for minimally invasive procedures.
The development of the market is facilitated by additional factors such as the technological advancement of endometrial ablation and its advantages over surgical techniques. Endometrial ablation also has several advantages over other surgical procedures, including faster recovery, less pain, minimal invasion, and shorter operation times.
Get a sample PDF of this research report with a detailed table of contents:
These elements contribute to an increase in the demand for endometrial ablation worldwide. However, the stringent government rules in approving endometrial ablation devices and the risks of endometrial ablation are expected to limit the market expansion to some extent.
Key insights from market research
Radio frequency ablation equipment currently accounts for the largest market share among all technologies and is also expected to maintain its dominance over the coming years.
Due to improvements in endometrial ablation technologies that do not require much space and can therefore be used in clinics, the clinic segment currently represents the largest revenue generation.
Due to its large population, growing demand for minimally invasive treatments, expanding healthcare infrastructure and growing awareness of endometrial ablation procedures, Asia Pacific offers profitable offers potential for market players selling endometrial ablation equipment.
Sales of endometrial ablation devices are expected to grow at a CAGR of 4% from 2022 to 2027.
Talk to the analyst:
Endometrial Ablation Devices Industry Research Segments
By Product :
By End User :
By Region :
South Asia and Oceania
The market is quite competitive as there are many national and international companies. Leading companies use various growth strategies to capture a substantial share of the market, including new product development, product differentiation strategies, financing, etc.
A majority of manufacturers focus on buying technologies created by competitors to expand their product line. Despite the consolidation of the endometrial ablation device market, new competitors are entering it by launching a variety of endometrial ablation products and accessories.
For more 350 million US dollarsMedtronic plc purchased the gynecology division of Smith & Nephew in 2016. Through this agreement, Medtronic acquired TRUCLEAR System, a critical gynecology product from Smith & Nephew.
In 2019, following Aveta’s FDA approval, ShangBay Capital LLC and Aethan Capital, Inc. held a $13 million equity financing round for Meditrina Inc. This illustrates the growth potential of the hysteroscopy systems market over the anticipated duration.
Quick buy – Endometrial Ablation Devices Market Research report:
Rise in Endometriosis Cases Drives Demand for Endometrial Ablation Devices
The US Department of Health and Human Services estimates that 11% of US women have endometriosis, which causes inflammation when tissues react to monthly variations in a woman’s menstrual cycle.
According to this data, the growing number of medical cases and large patient pool in the country are driving the expansion of the market.
Patient health and safety outcomes are of the utmost importance in the United States, and many initiatives have been launched to improve healthcare quality and reduce costs. Another driver for the expansion of the market in the United States is its high healthcare expenditure.
Check out other related studies published by Fact.MR Research:
Nerve Ablation Devices Market– Nerves are the vital part of the body, responsible for transmitting signals from different parts of the body to the brain. Nerves carry electrical signals that affect actions such as pain and other body movements. Nerve ablation devices are used to treat the patient through minimally invasive procedures, where a microelectrode is inserted inside the patient to heat the nerve tissue. According to the US Department of Health and Human Services, NIH over the past year or so. 40 million adults suffer from severe pain and approx. 25.3 million adults have suffered from pain every day for 3 months.
Atrial Fibrillation (AF) Ablation Market– Arterial fibrillation is a disease that creates an irregular and rapid heartbeat. Atrial fibrillation ablation is performed to treat the disease. The upper chambers of the heart beat irregularly and contract randomly at a very rapid rate, without coordination with the lower ventricles of the heart, which reduces the relaxation time of the heart muscle. According to the Center for Disease Control and Prevention (CDC), approximately 2.7 to 6.1 million people have atrial fibrillation in the United States. Additionally, nearly 750,000 hospitalizations occur each year due to atrial fibrillation, creating growth opportunities for atrial fibrillation ablation. market.
Neuroablation Devices Market – Euroablation devices are medical devices applied to iatrogenic lesions of peripheral nerves (PNI). A peripheral nerve is made up of axon, myelin, endoneurium, fascicle, perineurium and epineurium. Individual myelinated axons and groups of unmyelinated axons are usually surrounded by endoneurium. The growing prevalence of back pain, spinal injuries, neurological disorders and cancers is expected to be a major driver of the neuroablation devices market during the forecast period. For example, more than 80% of the world’s population suffers from lower back pain at least once in their life. At any one time, low back pain is prevalent in 4-33% of the population.
Cardiac Ablation Technology Market – Cardiac Ablation Technology market is expected to reach US$4,919.35 million in 2022, from US$4,427.89 million in 2021, representing an increase of 11.1% year-on-year. North America is expected to capture 37% of the global cardiac ablation technology market. , as it consists of leading players – Johnson & Johnson, Abbott and Boston Scientific Corporation.
Market research and consulting agency that makes the difference! That’s why 80% of Fortune 1000 companies trust us to make their most critical decisions. Although our experienced consultants use the latest technology to extract hard-to-find information, we believe that our USP is the trust our clients place in our expertise. Covering a wide range – from automotive and Industry 4.0 to healthcare and retail, our coverage is extensive, but we ensure that even the most niche categories are analyzed. Our sales offices in the USA and Dublin, Ireland. Headquarters based in Dubai, United Arab Emirates. Contact us with your goals and we will be a competent research partner.
USA Sales Office:
11140 Rockville Pike
Rockville, MD 20852
E-mail: [email protected]
Tel: +1 (628) 251-158